uracil has been researched along with Anemia in 28 studies
2,4-dihydroxypyrimidine: a urinary biomarker for bipolar disorder
Anemia: A reduction in the number of circulating ERYTHROCYTES or in the quantity of HEMOGLOBIN.
Excerpt | Relevance | Reference |
---|---|---|
"This study aimed to clarify the tolerability of a trifluridine/tipiracil combination tablet (TAS-102) in patients with advanced or recurrent colorectal cancer over 75 years of age." | 7.91 | Evaluation of Tolerability of Trifluridine/Tipiracil Combination Tablet in Patients With Advanced/Recurrent Colorectal Cancer. ( Kimura, M; Teramachi, H; Usami, E; Yoshimura, T, 2019) |
"Two phase III studies revealed an oral UFT/Leucovorin (LV) regimen, in which the drugs are taken for 28 consecutive days every 35 days, which proved to be equivalent to an infusional 5-fluorouracil/LV regimen for metastatic colorectal cancer (CRC)." | 5.12 | [Feasibility of weekday-on/weekend-off oral UFT/Leucovorin schedule as postoperative adjuvant chemotherapy for colorectal cancer]. ( Maeda, Y; Makuuchi, H; Murayama, C; Sadahiro, S; Suzuki, T, 2006) |
" This phase II study assessed the response rate and toxicity profile of the combination of epirubicin, cisplatin and UFT in patients with metastatic adenocarcinoma of the stomach." | 5.11 | A phase II study of epirubicin, cisplatin and uracil-tegafur for advanced gastric carcinoma. ( Byun, JH; Choi, MG; Chung, IS; Hong, YS; Kang, JH; Kim, KW; Lee, KS; Lee, MA; Moon, DH; Park, SY; Shim, BY; Woo, IS, 2005) |
"This study aimed to clarify the tolerability of a trifluridine/tipiracil combination tablet (TAS-102) in patients with advanced or recurrent colorectal cancer over 75 years of age." | 3.91 | Evaluation of Tolerability of Trifluridine/Tipiracil Combination Tablet in Patients With Advanced/Recurrent Colorectal Cancer. ( Kimura, M; Teramachi, H; Usami, E; Yoshimura, T, 2019) |
"Twenty-four patients with metastatic breast cancer that had progressed after high-dose chemotherapy with peripheral blood progenitor cell (PBPC) support were given intramuscular methotrexate in combination with oral UFT (tegafur and uracil) and oral leucovorin (the MUL regimen)." | 3.69 | Preliminary results. UFT/methotrexate/leucovorin for breast Ca patients in progression after HDCT/PBPC support. ( Ayala, F; Casado, A; Diaz-Rubio, E; López-Martin, JA; Martin, M; Nieto, Y; Rodriguez-Lescure, A, 1997) |
"Increased extracellular concentrations of uridine (Urd) have been reported to reduce, in vitro, azidothymidine (AZT)-induced inhibition of human granulocyte-macrophage progenitor cells without impairment of its antihuman immunodeficiency virus (HIV) activity." | 3.68 | Benzylacyclouridine reverses azidothymidine-induced marrow suppression without impairment of anti-human immunodeficiency virus activity. ( Calabresi, P; Chu, SH; Darnowski, JW; Falcone, A; St Clair, MH; Wiemann, MC, 1990) |
" However, information about the rate of adverse events (AEs) across different DAA regimens is limited." | 2.87 | Outcome and adverse events in patients with chronic hepatitis C treated with direct-acting antivirals: a clinical randomized study. ( Andersen, ES; Bukh, J; Christensen, PB; Fahnøe, U; Gerstoft, J; Kjær, MS; Laursen, AL; Mössner, B; Pedersen, MS; Røge, BT; Schønning, K; Sølund, C; Weis, N, 2018) |
" Major adverse events were neutropenia, leukopenia, anemia, and nausea." | 2.82 | Effect of food on the pharmacokinetics of TAS-102 and its efficacy and safety in patients with advanced solid tumors. ( Bando, H; Doi, T; Fuse, N; Goto, K; Ito, Y; Kojima, T; Mukai, H; Naito, Y; Ohtsu, A; Yamazaki, T; Yoshino, T, 2016) |
"Gastric cancer is the most chemosensitive adenocarcinoma among digestive neoplasms." | 2.68 | The UFT/leucovorin/etoposide regimen for the treatment of advanced gastric cancer. Oncopaz Cooperative Group. ( Belón, J; de Castro, J; Espinosa, E; Feliu, J; García Alfonso, P; García Girón, C; Garrido, P; González Barón, M; Lomas, M; Ordóñez, A; Zamora, P, 1997) |
"In the interferon era, the treatment of hepatitis C virus (HCV) infection in patients on haemodialysis (HD) was limited due to the significant number of treatment-related adverse events (AEs)." | 1.51 | Elimination of hepatitis C virus infection from a hemodialysis unit and impact of treatment on the control of anemia. ( Arias, M; Belmar, L; González, LN; Laguno, M; Llovet, LP; Londoño, MC; Maduell, F; Mallolas, J; Martínez-Rebollar, M; Ojeda, R; Rodas, L; Rossi, F; Ugalde, J, 2019) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 12 (42.86) | 18.7374 |
1990's | 6 (21.43) | 18.2507 |
2000's | 4 (14.29) | 29.6817 |
2010's | 5 (17.86) | 24.3611 |
2020's | 1 (3.57) | 2.80 |
Authors | Studies |
---|---|
Wiegand, J | 1 |
Buggisch, P | 1 |
Mauss, S | 1 |
Boeker, KHW | 1 |
Klinker, H | 1 |
Müller, T | 1 |
Günther, R | 1 |
Serfert, Y | 1 |
Manns, MP | 1 |
Zeuzem, S | 1 |
Berg, T | 1 |
Hinrichsen, H | 1 |
C-Registry, GH | 1 |
Liu, Y | 1 |
Li, X | 1 |
Li, A | 1 |
Li, K | 1 |
Qin, X | 1 |
Sølund, C | 1 |
Andersen, ES | 1 |
Mössner, B | 1 |
Laursen, AL | 1 |
Røge, BT | 1 |
Kjær, MS | 1 |
Gerstoft, J | 1 |
Christensen, PB | 1 |
Pedersen, MS | 1 |
Schønning, K | 1 |
Fahnøe, U | 1 |
Bukh, J | 1 |
Weis, N | 1 |
Maduell, F | 1 |
Belmar, L | 1 |
Ugalde, J | 1 |
Laguno, M | 1 |
Martínez-Rebollar, M | 1 |
Ojeda, R | 1 |
Arias, M | 1 |
Rodas, L | 1 |
Rossi, F | 1 |
Llovet, LP | 1 |
González, LN | 1 |
Mallolas, J | 1 |
Londoño, MC | 1 |
Kimura, M | 1 |
Usami, E | 1 |
Teramachi, H | 1 |
Yoshimura, T | 1 |
Yoshino, T | 1 |
Kojima, T | 1 |
Bando, H | 1 |
Yamazaki, T | 1 |
Naito, Y | 1 |
Mukai, H | 1 |
Fuse, N | 1 |
Goto, K | 1 |
Ito, Y | 1 |
Doi, T | 1 |
Ohtsu, A | 1 |
FROMMEYER, WB | 2 |
SPIES, TD | 2 |
TENTORI, L | 1 |
VIVALDI, G | 1 |
PARREIRA, F | 2 |
CARONIA, F | 2 |
PAGLIARO, L | 2 |
PICCARDO, MG | 2 |
VIETTI, TJ | 1 |
BERRY, DH | 1 |
FERNBACH, DJ | 1 |
LUSHER, J | 1 |
SUTOW, WW | 1 |
Reisner, M | 1 |
Carmeli, S | 1 |
Werman, M | 1 |
Sukenik, A | 1 |
VILTER, RW | 1 |
HORRIGAN, D | 1 |
MUELLER, JF | 1 |
JARROLD, T | 1 |
VILTER, CF | 1 |
HAWKINS, V | 1 |
SEAMAN, A | 1 |
Woo, IS | 1 |
Moon, DH | 1 |
Shim, BY | 1 |
Lee, MA | 1 |
Byun, JH | 1 |
Kim, KW | 1 |
Kang, JH | 1 |
Choi, MG | 1 |
Chung, IS | 1 |
Hong, YS | 1 |
Park, SY | 1 |
Lee, KS | 1 |
Sadahiro, S | 1 |
Suzuki, T | 1 |
Maeda, Y | 1 |
Makuuchi, H | 1 |
Murayama, C | 1 |
Lacher, JR | 1 |
Campion, DE | 1 |
Park, JD | 1 |
Martin, M | 1 |
Casado, A | 1 |
López-Martin, JA | 1 |
Rodriguez-Lescure, A | 1 |
Nieto, Y | 1 |
Ayala, F | 1 |
Diaz-Rubio, E | 2 |
González-Larriba, JL | 1 |
Garcia Carbonero, I | 1 |
Sastre Valera, J | 1 |
Perez Segura, P | 1 |
Ichinose, Y | 1 |
Yano, T | 1 |
Kudoh, S | 1 |
Yoshimori, K | 1 |
Morikawa, T | 1 |
Kuba, M | 1 |
Niitani, H | 1 |
González Barón, M | 1 |
Espinosa, E | 1 |
Feliu, J | 1 |
Ordóñez, A | 1 |
Zamora, P | 1 |
de Castro, J | 1 |
García Girón, C | 1 |
García Alfonso, P | 1 |
Garrido, P | 1 |
Belón, J | 1 |
Lomas, M | 1 |
Colevas, AD | 1 |
Amrein, PC | 1 |
Gomolin, H | 1 |
Barton, JJ | 1 |
Read, RR | 1 |
Adak, S | 1 |
Benner, S | 1 |
Costello, R | 1 |
Posner, MR | 1 |
Calabresi, P | 2 |
Falcone, A | 2 |
St Clair, MH | 1 |
Wiemann, MC | 1 |
Chu, SH | 2 |
Darnowski, JW | 2 |
Ruprecht, RM | 1 |
Brunetti, I | 1 |
Shigehisa, M | 2 |
Attardi, G | 1 |
Parnas, H | 1 |
Hwang, MI | 1 |
Attardi, B | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Occult Hepatitis C Virus Infection In Hemodialysis Patients Who Achieved A Sustained Virological Response To Directly Acting Antiviral Drugs: Is It A Concern ?[NCT04719338] | 30 participants (Actual) | Interventional | 2021-03-01 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
8 trials available for uracil and Anemia
Article | Year |
---|---|
Outcome and adverse events in patients with chronic hepatitis C treated with direct-acting antivirals: a clinical randomized study.
Topics: 2-Naphthylamine; Adult; Anemia; Anilides; Antiviral Agents; Benzimidazoles; Carbamates; Cyclopropane | 2018 |
Effect of food on the pharmacokinetics of TAS-102 and its efficacy and safety in patients with advanced solid tumors.
Topics: Aged; Anemia; Antineoplastic Agents; Area Under Curve; Asian People; Biological Availability; Cross- | 2016 |
A phase II study of epirubicin, cisplatin and uracil-tegafur for advanced gastric carcinoma.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Prot | 2005 |
[Feasibility of weekday-on/weekend-off oral UFT/Leucovorin schedule as postoperative adjuvant chemotherapy for colorectal cancer].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anemia; Anorexia; Antineoplastic Combined Chem | 2006 |
Neoadjuvant therapy with cisplatin/fluorouracil vs cisplatin/UFT in locally advanced squamous cell head and neck cancer.
Topics: Adult; Aged; Alopecia; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous C | 1997 |
UFT plus cisplatin in advanced non-small-cell lung cancer: interim analysis of 67 patients.
Topics: Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cispla | 1997 |
The UFT/leucovorin/etoposide regimen for the treatment of advanced gastric cancer. Oncopaz Cooperative Group.
Topics: Anemia; Antidotes; Antineoplastic Combined Chemotherapy Protocols; Diarrhea; Drug Combinations; Etop | 1997 |
A phase II study of combined oral uracil and ftorafur with leucovorin for patients with squamous cell carcinoma of the head and neck.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anemia; Antimetabolites, Antineoplastic; Antin | 2001 |
20 other studies available for uracil and Anemia
Article | Year |
---|---|
Hepatitis C therapy with direct antiviral agents in patients with advanced chronic kidney disease: real-world experience of the German Hepatitis C-Registry (Deutsches Hepatitis C-Register).
Topics: 2-Naphthylamine; Acute Disease; Adult; Aged; Anemia; Anilides; Antiviral Agents; Benzimidazoles; Car | 2019 |
UHPLC Q-Exactive MS-based spleen metabolomics and lipidomics to explore the effect mechanisms of Danggui Buxue Decoction in anemia mice.
Topics: Anemia; Animals; Biomarkers; Chromatography, High Pressure Liquid; Cytosine; Disease Models, Animal; | 2020 |
Elimination of hepatitis C virus infection from a hemodialysis unit and impact of treatment on the control of anemia.
Topics: 2-Naphthylamine; Anemia; Anilides; Antiviral Agents; Carbamates; Cyclopropanes; Darbepoetin alfa; Fe | 2019 |
Evaluation of Tolerability of Trifluridine/Tipiracil Combination Tablet in Patients With Advanced/Recurrent Colorectal Cancer.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Co | 2019 |
Relative clinical and hematologic effects of concentrated liver extract, synthetic folic acid and synthetic 5-methyl uracil in the treatment of macrocytic anemias in relapse.
Topics: Anemia; Anemia, Macrocytic; Folic Acid; Liver; Liver Extracts; Recurrence; Uracil; Vitamin B Complex | 1947 |
Further observations on the anti-anemic properties of 5-methyl uracil.
Topics: Anemia; Uracil; Vitamin B Complex; Vitamins | 1946 |
[Effect of uracil and methionine administered separately and simultaneously in experimental macrocytic anemia in rat].
Topics: Anemia; Anemia, Macrocytic; Animals; Methionine; Rats; Tracheophyta; Uracil | 1953 |
[In vitro effect of vitamin B 12, folic acid and uracil on bone marrow in two cases of megaloblastic anemia; preliminary note].
Topics: Anemia; Anemia, Megaloblastic; Bone Marrow; Folic Acid; Humans; In Vitro Techniques; Uracil; Vitamin | 1953 |
[In vitro effect of vitamin B12, folic acid and uracil on bone marrow in two cases of megaloblastic anemia].
Topics: Anemia; Anemia, Megaloblastic; Bone Marrow; Folic Acid; Humans; In Vitro Techniques; Uracil; Vitamin | 1953 |
[Correlation of biochemical data, clinical aspects and therapeutic reaction in megaloblastosis].
Topics: Anemia; beta-Thalassemia; Corrinoids; Erythroblasts; Folic Acid; Hematinics; Humans; Uracil; Vitamin | 1956 |
[Correlation of biochemical data, clinical aspects and therapeutic reaction in megaloblastosis].
Topics: Anemia; beta-Thalassemia; Corrinoids; Erythroblasts; Folic Acid; Hematinics; Humans; Uracil; Vitamin | 1956 |
[Correlation of biochemical data, clinical aspects and therapeutic reaction in megaloblastosis].
Topics: Anemia; beta-Thalassemia; Corrinoids; Erythroblasts; Folic Acid; Hematinics; Humans; Uracil; Vitamin | 1956 |
[Correlation of biochemical data, clinical aspects and therapeutic reaction in megaloblastosis].
Topics: Anemia; beta-Thalassemia; Corrinoids; Erythroblasts; Folic Acid; Hematinics; Humans; Uracil; Vitamin | 1956 |
URACIL MUSTARY THERAPY IN METASTATIC WILMS'S TUMOR.
Topics: Anemia; Child; Drug Therapy; Leukopenia; Nausea; Neoplasm Metastasis; Nitrogen Mustard Compounds; Th | 1964 |
The cyanobacterial toxin cylindrospermopsin inhibits pyrimidine nucleotide synthesis and alters cholesterol distribution in mice.
Topics: Alkaloids; Anemia; Anemia, Hypochromic; Animals; Bacterial Toxins; Cholesterol; Cyanobacteria; Cyano | 2004 |
Studies on the relationships of vitamin B12, folic acid, thymine, uracil and methyl group donors in persons with pernicious anemia and related megaloblastic anemias.
Topics: Anemia; Anemia, Megaloblastic; Anemia, Pernicious; Folic Acid; Hematinics; Thymine; Tissue Donors; U | 1950 |
Near Infrared Absorption Spectra of Uracil, 5-Chlorouracil, and Thymine.
Topics: Anemia; Humans; Thiourea; Thymine; Uracil | 1949 |
Preliminary results. UFT/methotrexate/leucovorin for breast Ca patients in progression after HDCT/PBPC support.
Topics: Adult; Anemia; Antidotes; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Diarrhea | 1997 |
Benzylacyclouridine reverses azidothymidine-induced marrow suppression without impairment of anti-human immunodeficiency virus activity.
Topics: Anemia; Animals; Cell Line; Cytopathogenic Effect, Viral; Female; HIV; Leukopenia; Mice; Mice, Inbre | 1990 |
Different effect of benzylacyclouridine on the toxic and therapeutic effects of azidothymidine in mice.
Topics: Acquired Immunodeficiency Syndrome; Anemia; Animals; Dose-Response Relationship, Drug; Female; Kinet | 1990 |
Studies on the relation between heme and nucleic acid syntheses in erythroid cell. II. Nucleic acid synthesis in erythroblast of anemic rat treated with aminopterin and bromouracil.
Topics: Aminopterin; Anemia; Animals; Bromine; Cell Nucleus; DNA; Erythrocytes; Phenylhydrazines; Rats; RNA; | 1968 |
Studies on the relation between heme and nucleic acid syntheses in erythroid cell. 3. Nucleolus of erythroblast, changes in relation with cell specialization.
Topics: Aminopterin; Anemia; Animals; Bone Marrow Cells; Cell Nucleolus; Culture Techniques; Cytoplasm; Eryt | 1969 |
Giant-size rapidly labeled nuclear ribonucleic acid and cytoplasmic messenger ribonucleic acid in immature duck erythrocytes.
Topics: Adenine; Anemia; Animals; Carbon Isotopes; Cell Nucleus; Chromatography, Ion Exchange; Cytosine; Dac | 1966 |